HCG experience of modified FOLFIRINOX regimen in advanced pancreatic cancer

被引：0
|
作者：
Satheesh, Thungappa [1 ]
Shashidhara, P. [1 ]
Ravi, Thippeswamy [2 ]
Shekar, Patil [1 ]
机构：
[1] Hlth Care Global, Bangalore, Karnataka, India
[2] Sri Shankara Canc Res Ctr, Bangalore, Karnataka, India
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-218
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience
    Ghorani, Ehsan
    Wong, Han Hsi
    Hewitt, Carole
    Calder, Joanna
    Corrie, Pippa
    Basu, Bristi
    ONCOLOGY, 2015, 89 (05) : 281 - 287
  • [32] Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
    Nanda, Ronica H.
    El-Rayes, Bassel
    Maithel, Shishir K.
    Landry, Jerome
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (08) : 1028 - 1034
  • [33] Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience.
    Lee, Jongchan
    Lee, Jong-Chan
    Kim, Hyoung Woo
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancer
    Xu, Xifeng
    Wu, Qiong
    Wang, Zhen
    Zheng, Song
    Ge, Ke
    Jia, Changku
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (01) : 149 - 157
  • [35] Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancer
    Xifeng Xu
    Qiong Wu
    Zhen Wang
    Song Zheng
    Ke Ge
    Changku Jia
    Clinical and Experimental Medicine, 2019, 19 : 149 - 157
  • [36] Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer
    Karachaliou, Georgia-Sofia
    Lazarou, Vasiliki
    Giannis, Dimitrios
    Astras, George
    Moris, Dimitrios
    Petrou, Athanasios
    JOURNAL OF BUON, 2020, 25 (05): : 2525 - 2527
  • [37] Retrospective review of FOLFIRINOX in local advanced pancreatic cancer: Single institution experience.
    Manne, Ashish
    Reddy, Sushanth
    Heslin, Martin
    Jacob, Rojymon
    Vickers, Selwyn M.
    Contreras, Carlo M.
    Kasi, Anup
    Christein, John
    Li, Peng
    Posey, James
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma
    Gilabert, Marine
    Chanez, Brice
    Rho, Young Soo
    Giovanini, Marc
    Turrini, Olivier
    Batist, Gerald
    Kavan, Petr
    Raoul, Jean Luc
    MEDICINE, 2017, 96 (16)
  • [40] Beyond FOLFIRINOX? The evolution of the treatment of advanced pancreatic cancer
    Lewandowski, Tomasz
    Biernacka, Renata
    Szmyd, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (05): : 191 - 196
12345